Continue to site >
Trending ETFs
You have successfully subscribed to Advisor Access. Thank you!
Help us personalize your experience.
Which type of investor describes you best?
Help us personalize your experience.
What is your AUM?
Knowing your investable assets will help us build and prioritize features that will suit your investment needs.

Congratulations on personalizing your experience.

Email is verified. Thank you!

Name

As of 05/03/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

First Trust Indxx Medical Devices ETF

MDEV | ETF

$20.35

$3.2 M

0.00%

0.70%

Vitals

YTD Return

0.8%

1 yr return

-3.7%

3 Yr Avg Return

N/A

5 Yr Avg Return

N/A

Net Assets

$3.2 M

Holdings in Top 10

23.3%

52 WEEK LOW AND HIGH

$20.2
$16.37
$21.51

Expenses

OPERATING FEES

Expense Ratio 0.70%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover N/A

Redemption Fee N/A

Min Investment

Standard (Taxable)

N/A

IRA

N/A

Fund Classification

Fund Type

Exchange Traded Fund

Name

As of 05/03/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

First Trust Indxx Medical Devices ETF

MDEV | ETF

$20.35

$3.2 M

0.00%

0.70%

MDEV - Profile

Distributions

  • YTD Total Return 0.8%
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio N/A
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name
    First Trust Indxx Medical Devices ETF
  • Fund Family Name
    First Trust Advisors L.P.
  • Inception Date
    Jun 22, 2021
  • Shares Outstanding
    N/A
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Chris Peterson

Fund Description

Under normal market conditions, the Fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the securities that comprise the Index. The Fund, using an indexing investment approach, attempts to replicate, before fees and expenses, the performance of the Index. The Fund will generally employ a full replication strategy, meaning that it will normally invest in all of the securities comprising the Index in proportion to their weightings in the Index. The Index is developed, maintained and sponsored by Indxx, Inc. (the “Index Provider”). The Index Provider reserves the right to use qualitative judgment to include, exclude, adjust, or postpone the inclusion of a stock in the Index. Continued Index membership of a constituent is not necessarily subject to the guidelines provided in the Index methodology. A stock may be considered for exclusion by the Index Provider on the basis of corporate governance, accounting policies, lack of transparency and lack of representation, despite meeting all the criteria provided in the Index methodology.The Index is composed of common stock and depositary receipts issued by U.S. and non-U.S. companies that comprise the medical devices industry, as determined by the Index Provider. According to the Index Provider, companies comprising the medical devices industry are those companies that focus on developing equipment, instruments, and machines to diagnose, monitor and treat diseases. The Fund may invest in securities denominated in non-U.S. currencies and companies with various market capitalizations, including small capitalization companies.The Index’s starting universe consists of all medical device companies listed in a developed market or emerging market, as defined by the Index Provider. In addition, a company’s stock must meet the size and liquidity requirements of the Index. According to the Index Provider, eligible medical device companies that derive a minimum of 50% of their total revenue from business activities related to developing equipment, instruments and machines to diagnose, monitor and treat diseases form the Index’s selection list. From the Index’s selection list, the top 50 companies based on market capitalization construct the final Index. The constituents are equally-weighted within the Index.The Index is rebalanced semi-annually and reconstituted annually, and the Fund will make corresponding changes to its portfolio shortly after the Index changes are made public. The Fund will be concentrated (i.e., invest more than 25% of Fund assets) in an industry or a group of industries to the extent that the Index is so concentrated. As of June 30, 2023, the Index had significant investments in health care companies and European issuers, although this may change from time to time.The Fund's investments will change as the Index changes and, as a result, the Fund may have significant investments in jurisdictions or investment sectors that it may not have had as of June 30, 2023. To the extent the Fund invests a significant portion of its assets in a given jurisdiction or investment sector, the Fund may be exposed to the risks associated with that jurisdiction or investment sector.The Fund is classified as “non-diversified” under the Investment Company Act of 1940, as amended (the “1940 Act”).
Read More

MDEV - Performance

Return Ranking - Trailing

Period MDEV Return Category Return Low Category Return High Rank in Category (%)
YTD 0.8% -25.6% 23.4% 98.32%
1 Yr -3.7% -30.0% 21.8% N/A
3 Yr N/A* -18.7% 19.7% N/A
5 Yr N/A* -14.7% 15.3% N/A
10 Yr N/A* -6.2% 15.7% N/A

* Annualized

Return Ranking - Calendar

Period MDEV Return Category Return Low Category Return High Rank in Category (%)
2023 7.6% -53.9% 11.7% N/A
2022 -28.6% -22.3% 18.5% N/A
2021 N/A -4.7% 41.4% N/A
2020 N/A -10.2% 13.1% N/A
2019 N/A -5.7% 26.9% N/A

Total Return Ranking - Trailing

Period MDEV Return Category Return Low Category Return High Rank in Category (%)
YTD 0.8% -41.2% 23.4% 99.44%
1 Yr -3.7% -30.0% 28.3% N/A
3 Yr N/A* -18.7% 19.7% N/A
5 Yr N/A* -14.7% 15.3% N/A
10 Yr N/A* -6.2% 15.7% N/A

* Annualized

Total Return Ranking - Calendar

Period MDEV Return Category Return Low Category Return High Rank in Category (%)
2023 7.6% -53.9% 11.7% N/A
2022 -28.6% -22.3% 18.5% N/A
2021 N/A -4.7% 41.4% N/A
2020 N/A -10.2% 13.1% N/A
2019 N/A -5.7% 26.9% N/A

MDEV - Holdings

Concentration Analysis

MDEV Category Low Category High MDEV % Rank
Net Assets 3.2 M 732 K 46.2 B 95.63%
Number of Holdings 51 21 473 74.35%
Net Assets in Top 10 706 K 2.18 K 21.6 B 96.34%
Weighting of Top 10 23.33% 12.3% 80.8% 95.29%

Top 10 Holdings

  1. Insulet Corp 2.72%
  2. Dexcom Inc 2.71%
  3. Masimo Corp 2.51%
  4. Carl Zeiss Meditec AG 2.24%
  5. Sonova Holding AG 2.24%
  6. Sartorius Stedim Biotech 2.23%
  7. Terumo Corp 2.20%
  8. Teleflex Inc 2.18%
  9. Waters Corp 2.17%
  10. PENUMBRA INC 2.13%

Asset Allocation

Weighting Return Low Return High MDEV % Rank
Stocks 		99.75% 85.37% 106.13% 34.03%
Cash 		0.25% -0.10% 9.01% 62.83%
Preferred Stocks 		0.00% 0.00% 7.86% 9.42%
Other 		0.00% -22.99% 3.38% 23.04%
Convertible Bonds 		0.00% 0.00% 0.37% 8.90%
Bonds 		0.00% 0.00% 12.39% 5.24%

Stock Sector Breakdown

Weighting Return Low Return High MDEV % Rank
Utilities 		0.00% 0.00% 0.00% 2.62%
Technology 		0.00% 0.00% 22.69% 9.95%
Real Estate 		0.00% 0.00% 7.13% 7.85%
Industrials 		0.00% 0.00% 7.02% 7.85%
Healthcare 		0.00% 59.26% 100.00% 1.57%
Financial Services 		0.00% 0.00% 1.85% 25.65%
Energy 		0.00% 0.00% 0.00% 2.62%
Communication Services 		0.00% 0.00% 9.11% 6.28%
Consumer Defense 		0.00% 0.00% 25.73% 14.14%
Consumer Cyclical 		0.00% 0.00% 14.20% 7.85%
Basic Materials 		0.00% 0.00% 14.83% 31.41%

Stock Geographic Breakdown

Weighting Return Low Return High MDEV % Rank
US 		62.30% 53.67% 104.41% 98.95%
Non US 		37.44% 0.00% 45.40% 1.57%

MDEV - Expenses

Operational Fees

MDEV Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.70% 0.08% 3.13% 63.40%
Management Fee 0.70% 0.00% 1.25% 60.66%
12b-1 Fee N/A 0.00% 1.00% 2.35%
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

MDEV Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

MDEV Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

MDEV Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 0.00% 238.00% 10.96%

MDEV - Distributions

Dividend Yield Analysis

MDEV Category Low Category High MDEV % Rank
Dividend Yield 0.00% 0.00% 2.44% 24.49%

Dividend Distribution Analysis

MDEV Category Low Category High Category Mod
Dividend Distribution Frequency Quarterly Annually Quarterly Annually

Net Income Ratio Analysis

MDEV Category Low Category High MDEV % Rank
Net Income Ratio N/A -2.54% 1.92% 62.13%

Capital Gain Distribution Analysis

MDEV Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Distributions History

View More +

MDEV - Fund Manager Analysis

Managers

Chris Peterson

Start Date

Tenure

Tenure Rank

Jun 22, 2021

0.94

0.9%

Chris A. Peterson, CFA was born in 1975. Mr. Peterson earned a B.S in Finance from Bradley University and has an MBA from the University of Chicago Booth School of Business with concentrations in Analytic Finance & Accounting. He has been with First Trust Advisors L.P. since 2000. As head of FTA’s Portfolio Advisor’s Strategy Research Group, Mr. Peterson shall be responsible for developing and implementing quantitative equity strategies on behalf of the Investment Committee.

Erik Russo

Start Date

Tenure

Tenure Rank

Jun 22, 2021

0.94

0.9%

Mr. Russo is a Vice President of First Trust. He is responsible for implementing the investment strategies of each portfolio of exchange-traded funds advised by First Trust in his role as a Portfolio Manager. Mr. Russo joined First Trust in January of 2010.

Roger Testin

Start Date

Tenure

Tenure Rank

Jun 22, 2021

0.94

0.9%

Roger F. Testin, CFA, was born in 1966. Mr. Testin earned a B.S. in Accounting from the University of Illinois and has an MBA in Finance from the University of Chicago. He has been with First Trust Advisors L.P. since 2001 and he is a Portfolio Manager and Senior Vice President. As Product Manager for the VA’s, SMA’s and International Managed Products, Mr. Testin shall be responsible for the daily implementation and execution of the strategies for these product vehicles on behalf of the Investment Committee.

Daniel Lindquist

Start Date

Tenure

Tenure Rank

Jun 22, 2021

0.94

0.9%

Daniel J. Lindquist, CFA, was born in 1970. Mr. Lindquist earned a B.A. in Business Economics from Wheaton College and has an MBA in Finance from the University of Chicago. He has been with First Trust Advisors L.P. since 2004 and is a Managing Director. Mr. Lindquist is the Chairman of the Investment Committee and is responsible for the overall supervision of the Separate Managed Accounts.

Jon Erickson

Start Date

Tenure

Tenure Rank

Jun 22, 2021

0.94

0.9%

Jon C. Erickson, CFA, was born in 1966. Mr. Erickson earned a B.S. in Computer Science from the University of Illinois and has an MBA from the University of Illinois in Finance. He has been with First Trust Advisors L.P. since 1994 and he is a Portfolio Manager and Senior Vice President. As the head of FTA’s Equity Research Group, Mr. Erickson shall be responsible for determining the securities to be purchased and sold by Funds that do not utilize quantitative investment strategies on behalf of the Investment Committee.

David McGarel

Start Date

Tenure

Tenure Rank

Jun 22, 2021

0.94

0.9%

David G. McGarel, CFA, was born in 1966. Mr. McGarel earned a B.S. in Accounting from the University of Notre Dame. He has been with First Trust Advisors L.P. since 1997 and he is a Managing Director, Chief Operating Officer and the Chief Investment Officer. As head of FTA’s Strategy Research Group, Mr. McGarel shall be responsible for developing and implementing quantitative investment strategies for those Funds that have investment policies that require them to follow such strategies, on behalf of the Investment Committee.

Stan Ueland

Start Date

Tenure

Tenure Rank

Jun 22, 2021

0.94

0.9%

Mr. Ueland joined First Trust Advisors as a Vice President in August 2005 and has been a Senior Vice President of First Trust and FTP since September 2012. At First Trust, he plays an important role in executing the investment strategies of each portfolio of exchange-traded funds advised by First Trust. Before joining First Trust, he was vice president of sales at BondWave LLC from May 2004 through August 2005, an account executive for Mina Capital Management LLC and Samaritan Asset Management LLC from January 2003 through May 2004, and a sales consultant at Oracle Corporation from January 1997 through January 2003.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.26 2.12

Advertisement

×

Wait! Do you know all the important aspects of mutual funds?

×

Free Advisor Access newsletter emailed to you.

Receive free and exclusive email updates for financial advisors about best performers, news, CE accredited webcasts and more.

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Disclaimer: By registering, you agree to share your data with MutualFunds.com and opt-in to receiving occasional communications about projects and events. The contents of this form are subject to the MutualFunds.com Privacy Policy. You can unsubscribe at any time.